Effects of in vitro glycation on Fe3+ binding and Fe3+ isoforms of transferrin.

BACKGROUND In diabetes, protein function is altered by glycation, but the impact on the Fe3+ binding and antioxidant functions of transferrin (Tf) is largely unknown. The aim of the present study was to investigate the effects of glycation on the distribution of Fe3+ on the two Fe3+ -binding sites of Tf. METHODS In vitro glycation of Tf was accomplished by preincubation with glucose for 14 days. Tf was loaded with Fe3+ compounds to achieve theoretical Tf Fe3+ saturations of 32%, 64%, and 96% (monitored by spectrophotometry). Fe3+ -Tf isoforms were separated by isoelectric focusing. RESULTS Fe3+ binding was highest when Tf was incubated with Fe:nitrilotriacetic acid and reached a steady state overnight. Increasing the Fe3+ load led to a shift of isoform profile toward the diferric form (Fe2-Tf): in freshly prepared Tf, Fe2-Tf represented 6%, 30%, and 66% of all isoforms at 32%, 64%, and 96% theoretical Fe3+ saturation, respectively. Fe3+ was equally distributed to the monoferric Tf forms with Fe3+ bound to the amino (Fe1N-Tf) and carboxy termini (Fe1C-Tf). Glycation decreased binding of Fe3+ to Tf (monitored at 450 nm). At low theoretical Fe3+ saturation (32%), glycation increased the mean (SD) proportion of Fe2-Tf: 18 (3)% in the presence of 33.3 mmol/L glucose vs 12 (4)% with 0 mmol/L glucose (P = 0.01). In contrast, at 96% theoretical Fe3+ saturation, Fe2-Tf decreased linearly with increasing glycation (r = 0.97; P = 0.008). Preincubation, independent of glycation, favored the Fe1N-Tf isoform at 64% theoretical Fe3+ saturation [27 (0.7)% vs 23 (1.1)% of the Fe1C-Tf isoform; P = 0.009]. CONCLUSIONS Glycation impairs Fe3+ binding and affects Fe3+ -Tf isoform distribution depending on concentration. The diagnostic implications of these results need further elucidation in clinical studies.

[1]  L. Messori,et al.  The pH dependent properties of metallotransferrins: a comparative study , 1997, Biometals.

[2]  H. Carchon,et al.  The carbohydrate-deficient glycoprotein syndromes: An overview , 1993, Journal of Inherited Metabolic Disease.

[3]  C. van Campenhout,et al.  Transferrin Modifications and Lipid Peroxidation: Implications in Diabetes Mellitus , 2003, Free radical research.

[4]  J. Fernández-Real,et al.  Cross-talk between iron metabolism and diabetes. , 2002, Diabetes.

[5]  S. Everse,et al.  Differential effect of a his tag at the N- and C-termini: functional studies with recombinant human serum transferrin. , 2002, Biochemistry.

[6]  O. Zak,et al.  The synergistic anion-binding sites of human transferrin: chemical and physiological effects of site-directed mutagenesis. , 2002, Biochemistry.

[7]  M. Schlabach,et al.  The Synergistic Binding of Anions and Fe 3 + by Transferrin , 2002 .

[8]  W. Breuer,et al.  A fluorescence-based one-step assay for serum non-transferrin-bound iron. , 2001, Analytical biochemistry.

[9]  A. Barden,et al.  Advanced Glycation End Products: A Review , 2013 .

[10]  S. Rauch.  Transferrin Microheterogeneity in Human Perilymph , 2000, The Laryngoscope.

[11]  M. Hirose.  The Structural Mechanism for Iron Uptake and Release by Transferrins , 2000, Bioscience, biotechnology, and biochemistry.

[12]  N. Martin,et al.  Smoking, obesity, and hypertension alter the dose-response curve and test sensitivity of carbohydrate-deficient transferrin as a marker of alcohol intake. , 1998, Clinical chemistry.

[13]  J. Eaton,et al.  Transition metals bind to glycated proteins forming redox active "glycochelates": implications for the pathogenesis of certain diabetic complications. , 1998, Biochemical and biophysical research communications.

[14]  E. Gunter,et al.  The Relation between Chemically Measured Total Iron-binding Capacity Concentrations and Immunologically Measured Transferrin Concentrations in Human Serum We Sought to Determine If Serum Total Iron-binding Capacity (tibc) Is Equivalent to Serum Transferrin (trf) so That a Low-cost Colorimetric Chemi , 2022 .

[15]  T. Lakka,et al.  Body Iron Stores Are Associated With Serum Insulin and Blood Glucose Concentrations: Population study in 1,013 eastern Finnish men , 1997, Diabetes Care.

[16]  T. Arndt,et al.  Effect of separation conditions on automated isoelectric focusing of carbohydrate-deficient transferrin and other human isotransferrins using the PhastSystem. , 1995, Analytical biochemistry.

[17]  A. Ohara,et al.  Nonenzymatic glycation of transferrin: decrease of iron-binding capacity and increase of oxygen radical production. , 1995, Biological & pharmaceutical bulletin.

[18]  O. Zak,et al.  Primary receptor-recognition site of human transferrin is in the C-terminal lobe. , 1994, The Journal of biological chemistry.

[19]  M. Castagnola,et al.  Structure-function relationship in the serotransferrin: the role of the pH on the conformational change and the metal ions release. , 1994, Biochemical and biophysical research communications.

[20]  H. G. Eijk,et al.  Purification of Isotransferrins by Concanavalin A Sepharose Chromatography and Preparative Isoelectric Focusing , 1994 .

[21]  S. Wolff.  Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. , 1993, British medical bulletin.

[22]  J. Gutteridge,et al.  Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: the important primary role for iron-binding and iron-oxidising proteins. , 1992, Biochimica et biophysica acta.

[23]  H. G. Eijk,et al.  The analysis of human serum transferrins with the PhastSystem: Quantitation of microheterogeneity , 1992, Electrophoresis.

[24]  H. G. van Eijk,et al.  The analysis of human serum transferrins with the PhastSystem: Quantitation of microheterogeneity , 1992, Electrophoresis.

[25]  H Stibler,et al.  Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. , 1991, Clinical chemistry.

[26]  P. Aisen,et al.  Receptor-modulated iron release from transferrin: differential effects on N- and C-terminal sites. , 1991, Biochemistry.

[27]  J. Baynes.  Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.

[28]  J. V. Dijk,et al.  The biology of transferrin. , 1990 .

[29]  P. Cutler.  Deferoxamine Therapy in High-Ferritin Diabetes , 1989, Diabetes.

[30]  C. Finch,et al.  Random distribution of iron among the two binding sites of transferrin in patients with various hematologic disorders. , 1988, Clinica chimica acta; international journal of clinical chemistry.

[31]  H. G. Eijk,et al.  Microheterogeneity of human serum transferrin: A biological phenomenon studied by isoelectric focusing in immobilized pH gradients , 1988 .

[32]  H. G. van Eijk,et al.  Microheterogeneity of human serum transferrin: A biological phenomenon studied by isoelectric focusing in immobilized pH gradients , 1988, Electrophoresis.

[33]  L. Morin,et al.  Non-enzymic glycation of individual plasma proteins in normoglycemic and hyperglycemic patients. , 1987, Clinical chemistry.

[34]  R. Martin,et al.  Transferrin binding of Al3+ and Fe3+. , 1987, Clinical chemistry.

[35]  J. K. Grady,et al.  The influence of uncoordinated histidines on iron release from transferrin. A chemical modification study. , 1986, The Journal of biological chemistry.

[36]  O. Zak,et al.  Nonrandom distribution of iron in circulating human transferrin. , 1986, Blood.

[37]  R. Hunter,et al.  Quantitation of apo-, mono-, and diferric transferrin by polyacrylamide gradient gel electrophoresis in patients with disorders of iron metabolism. , 1985, Blood.

[38]  R. Chapman,et al.  Transferrin metabolism in alcoholic liver disease , 1985, Hepatology.

[39]  C. Finch,et al.  Occupancy of the iron binding sites of human transferrin. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[40]  W. R. Harris,et al.  Thermodynamic binding constants of the zinc-human serum transferrin complex. , 1983, Biochemistry.

[41]  W R Harris,et al.  Thermodynamic binding constants for gallium transferrin. , 1983, Biochemistry.

[42]  R. von Wandruszka,et al.  The effect of pH on the kinetics of iron release from human transferrin. , 1982, Biochimica et biophysica acta.

[43]  B. Halliwell,et al.  Superoxide-dependent formation of hydroxyl radicals and lipid peroxidation in the presence of iron salts. Detection of 'catalytic' iron and anti-oxidant activity in extracellular fluids. , 1982, The Biochemical journal.

[44]  J. Williams,et al.  The distribution of iron between the metal-binding sites of transferrin human serum. , 1980, The Biochemical journal.

[45]  P. Aisen,et al.  Distribution of iron between the binding sites of transferrin in serum: methods and results in normal human subjects. , 1979, Blood.

[46]  P. Aisen,et al.  Stoichiometric and site characteristics of the binding of iron to human transferrin. , 1978, The Journal of biological chemistry.

[47]  H. G. van Eijk,et al.  Analysis of the Iron-Binding Sites of Transferrin by Isoelectric Focussing , 1978, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[48]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[49]  M. Schlabach,et al.  The synergistic binding of anions and Fe3+ by transferrin. Implications for the interlocking sites hypothesis. , 1975, The Journal of biological chemistry.

[50]  M. Schlabach,et al.  The reaction of ferric salts with transferrin. , 1973, The Journal of biological chemistry.

[51]  J. Wernicke,et al.  The Kinetics and Mechanism of Iron (III) Exchange between Chelates and Transferrin IV. THE REACTION OF TRANSFERRIN WITH IRON(III) NITRILOTRIACETATE , 1971 .

[52]  P. Saltman,et al.  The kinetics and mechanism of iron (3) exchange between chelates and transferrin. I. The complexes of citrate and nitrilotriacetic acid. , 1967, The Journal of biological chemistry.

[53]  R. Aasa,et al.  THE SPECIFIC BINDING OF IRON(III) AND COPPER(II) TO TRANSFERRIN AND CONALBUMIN. , 1963, Biochimica et biophysica acta.

[54]  L. Strong,et al.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXVII. THE METAL-COMBINING GLOBULIN OF HUMAN PLASMA. , 1949, The Journal of clinical investigation.